Page 263 - Read Online

Idhrees et al. Vessel Plus 2020;4:23 I http://dx.doi.org/10.20517/2574-1209.2020.15 Page 9 of 10

efficacy of anti-TNFα treatment in two Italian siblings. Int J Clin Rheumatol 2018;13:341-5.
9. Chatterjee S, Flamm SD, Tan CD, Rodriguez ER. Clinical diagnosis and management of large vessel vasculitis: Takayasu arteritis. Curr
Cardiol Rep 2014;16:499.
10. Alibaz-Oner F, Aydin SZ, Direskeneli H. Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis. Clin Rheumatol
2013;32:541-6.
11. Devarasetti PK, Irlapati RV, Rajasekhar L. Pentraxin 3 is better than conventional inflammatory markers for disease activity assessment in
Takayasu arteritis. Indian J Rheumatol 2019;14:21-7.
12. Devarasetti PK, Appani SK, Irlapati RVP, Rajasekhar L. SAT0364 pentraxin 3 as biomarker in assessment of disease activity in Takayasu
arteritis. Ann Rheum Dis 2016;75:798.
13. Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayasu’s arteritis. Clin Exp Rheumatol
2011;29:S86-91.
14. Nair AM, Goel R, Hindhumati M, Jayakanthan K, Visalakshi J, et al. Serum amyloid A as a marker of disease activity and treatment
response in Takayasu arteritis. Rheumatol Int 2017;37:1643-9.
15. Goel R, Kabeerdoss J, Mohan H, Danda S, Jayaseelan V, et al. Soluble-HLA-E: a follow up biomarker in Takayasu arteritis, independent
of HLA-E genotype. Int J Rheum Dis 2018;21:532-40.
16. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu
arteritis patients. Arthritis Rheum 2007;56:1000-9.
17. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.
18. Kim ESH, Beckman J. Takayasu arteritis: challenges in diagnosis and management. Heart 2018;104:558-65.
19. Barra L, Kanji T, Malette J, Pagnoux C; CanVasc. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s
arteritis: a systematic review and meta-analysis. Autoimmun Rev 2018;17:175-87.
20. Miyata T, Sato O, Koyama H, Shigematsu H, Tada Y. Long-term survival after surgical treatment of patients with Takayasu’s arteritis.
Circulation 2003;108:1474-80.
21. Isobe M. Takayasu arteritis revisited: current diagnosis and treatment. Int J Cardiol 2013;168:3-10.
22. Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, et al. Overview of late outcome of medical and surgical treatment for Takayasu
arteritis. Circulation 2008;118:2738-47.
23. Fields CE, Bower TC, Cooper LT, Hoskin T, Noel AA, et al. Takayasu’s arteritis: operative results and influence of disease activity. J Vasc
Surg 2006;43:64-71.
24. Zhang Y, Yang K, Meng X, Tian T, Fan P, et al. Cardiac valve involvement in Takayasu arteritis is common: a retrospective study of 1,069
patients over 25 years. Am J Med Sci 2018;356:357-64.
25. Goel R, Gribbons KB, Carette S, Cuthbertson D, Hoffman GS, et al. Derivation of an angiographically based classification system in
Takayasu’s arteritis: an observational study from India and North America. Rheumatology (Oxford) 2020;59:1118-27.
26. Kihara M, Kimura K, Yakuwa H, Minamisawa K, Hayashi S, et al. Isolated left coronary ostial stenosis as the sole arterial involvement in
Takayasu’s disease. J Intern Med 1992;232:353-5.
27. Lanjewar C, Kerkar P, Vaideeswar P, Pandit S. Isolated bilateral coronary ostial stenosis - an uncommon presentation of aortoarteritis. Int
J Cardiol 2007;114:e126-8.
28. Lie JT. Pathology of isolated nonclassical and catastrophic manifestations of Takayasu arteritis. Int J Cardiol 1998;66 Suppl 1:S11-21.
29. Kang EJ, Kim SM, Choe YH, Lee GY, Lee KN, et al. Takayasu arteritis: assessment of coronary arterial abnormalities with 128-section
dual-source CT angiography of the coronary arteries and aorta. Radiology 2014;270:74-8.
30. Cipriano PR, Silverman JF, Perlroth MG, Griepp RB, Wexler L. Coronary arterial narrowing in Takayasu’s aortitis. Am J Cardiol
1977;39:744-50.
31. Amano J, Suzuki A. Coronary artery involvement in Takayasu’s arteritis. Collective review and guideline for surgical treatment. J Thorac
Cardiovasc Surg 1991;102:554-60.
32. Águeda AF, Monti S, Luqmani RA, Buttgereit F, Cid M, et al. Management of Takayasu arteritis: a systematic literature review informing
the 2018 update of the EULAR recommendation for the management of large vessel vasculitis. RMD Open 2019;5:e001020.
33. Keser G, Direskeneli H, Aksu K. Management of Takayasu arteritis: a systematic review. Rheumatology 2014;53:793-801.
34. Misra DP, Wakhlu A, Agarwal V, Danda D. Recent advances in the management of Takayasu arteritis. Int J Rheum Dis 2019;22 Suppl
1:60-8.
35. Tombetti E, Manfredi A, Sabbadini MG, Baldissera E. Management options for Takayasu arteritis. Expert Opin Orphan Drugs
2013;1:685-93.
36. Weaver FA, Yellin AE, Campen DH, Oberg J, Foran J, et al. Surgical procedures in the management of Takayasu’s arteritis. J Vasc Surg
1990;12:429-39.
37. Son JW, Koh KK, Dang Q, Choi IS, Shin EK. Recurrent restenosis following stent and rotational atherectomy of coronary artery stenosis
in Takayasu’s arteritis. Int J Cardiol 1998;65:295-300.
38. Jung JH, Lee YH, Song GG, Jeong HS, Kim JH, et al. Endovascular versus open surgical intervention in patients with Takayasu’s
arteritis: a meta-analysis. Eur J Vasc Endovasc Surg 2018;55:888-99.
39. Ueno M. Antiplatelet therapy in the treatment of Takayasu arteritis. Circ J 2010;74:1079-80.
40. Ueda H, Ito I, Saito Y. Studies on arteritis, with special reference to pulseless disease and its diagnosis. Naika 1965;15:239-56.
41. Yang Y, Tian T, Yang K, Zhang Y, Meng X, et al. Outcomes of percutaneous coronary intervention and coronary artery bypass grafting in
patients with Takayasu arteritis. Int J Cardiol 2017;241:64-9.